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Abstract.  The orientation in cellular membranes of 
the 856 amino acid envelope glycoprotein precursor, 
gpl60, of human immunodeficiency virus type 1 was 
investigated  in vitro. Variants  of the env gene were 
transcribed using the bacteriophage SP6 promoter, 
translated using a rabbit reticulocyte lysate, and trans- 
located into canine pancreatic microsomal membranes. 
Immunoprecipitation studies of gpl60 variants using 
antibodies specific for various gpl60-derived polypep- 
tides provided evidence that the external (cell surface) 
domain of gpl60 begins at the mature amino terminus 
of the protein and continues through amino acid 665. 
A stop-transfer sequence (transmembrane domain) was 
identified in a hydrophobic region COOH-terminal to 
amino acid 665  and NH2-terminal  to amino acid 732. 
Protease protection experiments demonstrated that 
gpl60 possesses a single cytoplasmic domain COOH- 
terminal to residue 707. Membrane extraction studies 
using carbonate buffer provided evidence that the 29 
amino acid hydrophobic domain (residues 512-541)  of 
gpl60 was unable to serve as a stop-transfer sequence. 
Finally, we propose that the cytoplasmic tail of gpl60 
forms a secondary association with the microsomal 
membranes. 
T 
HE human immunodeficiency virus  type 1 (HIV-1)  t 
has been identified as the etiologic agent of the ac- 
quired  immunodeficiency  syndrome  (AIDS;  Barrt- 
Sinoussi et al., 1983; Gallo et al., 1983; Curran et al., 1985; 
Weiss, 1986). In HIV-l-infected cells, the proviral envelope 
gene (env) directs the synthesis of a membrane-bound poly- 
glycoprotein,  gpl60,  that is modified by the attachment of 
numerous N-linked oligosaccharide side chains (Allan et al., 
1985).  Sometime  during  intracellular  transport  or  upon 
reaching the cell surface, gpl60 is proteolytically cleaved to 
give rise  to the two mature viral  envelope glycoproteins: 
gpl20 derived from the amino-terminal 510 amino acid resi- 
dues of the precursor,  and gp41 derived from carboxy-ter- 
minal  346  amino  acids  of the glycoprotein  (Allan et al., 
1985; DiMarzo-Veronese  et al., 1985). It is thought that gp41 
is an integral membrane  protein that  forms a noncovalent 
complex with the gpl20 on the surface of virions (Gelder- 
blom et al., 1985). Hydropathic analysis of gpl60 revealed 
that other than the amino-terminal signal sequence, two ad- 
ditional regions of prominent hydrophobicity were present, 
both of which were located in gp41 and consisted of amino 
acid residues 512-541 and 684-707, respectively (Muesing 
et al.,  1985). One or both of these regions might serve as 
a stop-transfer sequence (Blobel, 1980) by which the protein 
is stably incorporated into the lipid bilayer of either cellu- 
lar  or  viral  membranes.  To date,  two  models  have been 
presented to account for the orientation of gpl60 in biologi- 
1. Abbreviations used in this paper: endo H, endo-13-N-acetylglucosamini- 
dase H; gD-1, herpes simplex virus type 1 glycoprotein  D; HIV-1, human 
immunodeficiency  virus type 1; RIP, radioimmunoprecipitation;  Staph A, 
Staphylococcus  aureus. 
cal membranes. The first model, based on computer analysis 
and epitope mapping, postulated that both of  the hydrophobic 
domains in gp41 as well as sequences located between these 
domains were inserted into the viral membrane (Modrow et 
al.,  1987). More recently, this model has been called into 
question by two independent studies of  the expression of  var- 
ious deletion and truncation variants of  the gpl60 gene trans- 
fected into RAJI cells (Kowalski et al.,  1987) or Chinese 
hamster ovary (CHO) cells  (Berman et al.,  1988), which 
provided  evidence  that  variants  that  included  the  NH2- 
terminal hydrophobic domain of  gp41 in their sequence were 
secreted into the cell culture media. 
To understand the role of  gpl60 in the assembly and infec- 
tivity of HIV-1, it is important to define the extracellular as 
well as the intracellular domains of the viral glycoprotein. 
We have therefore attempted to clarify this issue by analyzing 
the topogenesis of gp160 in microsomal membranes through 
the use of  transcription-coupled translation and translocation 
systems (Milstein  et  al.,  1972; Blobel  and  Dobberstein, 
1975; Walter et al.,  1984). In these experiments, mRNAs 
transcribed  using  the  bacteriophage  SP6  promoter  were 
translated in rabbit reticulocyte lysates and the nascent pro- 
teins  translocated  across  canine  pancreatic  microsomal 
membranes. This approach allows access to the glycoprotein 
being studied and is thus more suited than in vivo systems 
for direct experimental manipulations.  The in vitro system 
has proved useful in defining the function of  hydrophobic do- 
mains from a variety of  viral envelope and cell surface glyco- 
proteins and in elucidating their topology in biological mem- 
branes (Perara and Lingappa, 1985; Holland and Drickamer, 
1986; Eble et al., 1986; Teixid6 et al., 1987; Zerial et al., 
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lar domain of gpl60 extends from the mature amino terminus 
(residue 31) through amino acid 665 to residue 683, and that 
the cytoplasmic tail consists of residues 708-856.  We also 
present novel evidence that indicates that the cytoplasmic tail 
loops back to interact with the membrane bilayer. 
Materials and Methods 
Plasmids and Nomenclature 
To enhance the expression of gpl60 and gpl60 variants in mammalian cells, 
the signal sequence of  the env gene from the HIV-1 (IIIB isolate) was deleted 
and replaced with that of herpes simplex virus type 1 glycoprotein D (gD-1) 
as described previously (Lasky et al.,  1986;  Rerman et al.,  1988).  This 
resulted in genes that encoded proteins containing the signal sequence and 
27 amino acid residues of gD-1 fused to amino acid 61 of native gpl60. The 
prefix "d" was used to designate chimeric genes containing the amino- 
terminal gD-1 gequences. The chimeric gpl60 gene and its truncated vari- 
ants are also assigned numerical designations that refer to the last amino 
acid residue of gpl60 before the translational stop codon. Thus, the gene 
containing the gD-1 signal sequence and 27 amino-terminal residues fused 
to residues 61-856 of  gpl60 is designated d856. To maintain uniformity with 
the literature, all numeric references to amino acid residues in the text is 
with reference to the methionine residue at position 1 of the native gpl60. 
The gene encoding the truncated variant d665 was constructed by mutagene- 
sis of the d856 gene using a mismatched synthetic DNA primer as described 
previously (Berman et al., 1988). Construction of  the truncated variant d531 
has been described elsewhere (Lasky et al., 1986). The d41Ct gene encodes 
a protein that contains the signal sequence and amino-terminal 27 amino 
acids of herpes simplex virus gD-1 fused to the carboxy-terminal region of 
gpl60 (amino acid residues 710-856). To assemble the d41et gene, the d856 
gene was cleaved at the codon corresponding to amino acid residue 724 by 
digestion with the endonuclease Ava I and the 5' sequences up to the codon 
for residue 710 restored by in frame ligation of a synthetic DNA fragment. 
This introduced a Kpn I site at the 5' end which was used for fusion to the 
gD-I sequences as described previously (Lasky et al.,  1986). 
In Vitro Transcription-coupled Translation 
The genes d856,  d665,  d531,  and d41Ct were inserted downstream of the 
bacteriophage SP6 promoter in a plasmid closely resembling that described 
by Eaton et al. (1986) and then transcribed in vitro according to a modified 
protocol of Melton et al. (1984).  Briefly, linearized plasmid DNA (1 ixg/ml) 
was transcribed in a 50-1~1 reaction volume at a final concentration of 0.1 
lag/ml, containing 10 p.15  ×  transcription buffer (200 mM Tris-HCl, pH 7.5, 
30  mM  MgC12, 20  mM  spermidine),  1.25  p,1  dithiothreitol (DTT;  0.2 
mM), 5 VA ribonucleotides (2.5 mM of each rATE rCTP, rUTP, and rGTP; 
P-L Biochemicals, Milwaukee,  WI),  1.25  p,l ribonuclease inhibitor (40 
U/I.d RNAsin; Promega Biotec, Madison, WI), 1 lal SP6 RNA polymerase 
(15 U/ial;  Riboprobe; Promega Biotec) and 26.5  Ixl sterilized water.  Tran- 
scription was allowed to proceed for 2 h at 40°C and then stoppe  d by lower- 
ing the temperature on ice. 
Aliquots of the transcription mixtures containing the appropriate mRNAs 
were translated in the presence of  canine pancreatic microsomal membranes 
(Promega Biotec) in a rabbit reticulocyte lysate system (Promega Biotec) ac- 
cording to the manufacturer's protocol. Briefly, 2 ILtl of transcription mixture 
were added to 35  I.tl rabbit reticulocyte lysate, 7 I.d L-[35S]methionine (15 
~tCi/p,l; Amersham Corp., Arlington Heights, IL) 1 Id amino acid mixture 
(1 mM minus methionine), 1 lal ribonuctease inhibitor, and 1 Ixl canine pan- 
creatic microsomal membranes (1 eq/~tl).  The volume was supplemented 
to 50 pA with sterilized water.  Translation was carried out at 30°C for 60 
min and stopped by chilling on ice. 
Antisera 
The antisera used in this study were raised in rabbits against specific regions 
of gpl60:PB33 was elicited against d531-encoded recombinant gpl20 in a 
manner similar to that described previously (Lasky et al., 1986); PB12 was 
elicited against an Escherichia coli fusion protein consisting of amino acid 
542-641 of gpl60 fused to the Trp E protein (Cabradilla et al., 1986); RK22 
(Kennedy et al., 1986,  1987) and RK773 antisera were kindly provided by 
Dr.  Ronald Kennedy and were elicited against synthetic peptides corre- 
sponding to residues 728-745  (DRPEGIEEEGGERDRDRS)  ~ and 839-853 
(AIRHIPRRIRQGLER; Chanh et al., 1988; R. Kennedy, personal commu- 
nication) of the cytoplasmic tail, respectively. The numbers of the amino 
acid residues as presented in this manuscript is based on the sequence of 
the H9 clone of the HIV-1 III B isolate (Meusing et al., 1985) and differs 
from the numbers provided by Chanh et al. (1988). 
RIP and Gel Electrophoresis 
To assay for HIV-1 proteins a specific radioimmunoprecipitation (RIP) pro- 
cedure was used whereby RIP lysis buffer (1% NP-40, 0.5% deoxycholate, 
0.1%  SDS  in PBS-solubilized L-[35S]methionine-radiolabeled cells were 
reacted with  the  appropriate  antisera  for  30  min  at  room temperature 
(22°C).  The antibody-antigen complexes were then incubated with 10% 
glutaraldehyde fixed Staphylococcus aureus (Staph A; Pansorbin; Calbio- 
chem-Behring Corp., San Diego, CA), and incubated for 30 rain at room 
temperature. The Staph A was preadsorbed with 2% heat inactivated FBS 
in PBS to reduce the nonspecific adsorption of proteins to the bacteria. The 
Staph A antibody-antigen complexes were sedimented by centrifugation and 
washed twice with RIP wash buffer (1%  NP-40,  0.1% SDS in PBS). The 
resulting pellets were solubilized with SDS-PAGE sample buffer (Laemmli, 
1970) and fractionated, unless otherwise specified in 7% polyacrylamide 
gels. 
Endo H Digestion 
Immunoprecipitated HIV-I proteins were released from the Staph A pellets 
by incubation in  1%  SDS/PBS solution for 10 rain at 22"C (Platt et al., 
1986;  John and  Firestone,  1986).  The supernatants were collected and 
treated with endo-I~-N-acetylglucosaminidase H (endo H) as described by 
Haffar et al. (1986).  After digestion, the HIV-1 proteins were immunopre- 
cipitated again and fractionated by SDS-PAGE. 
Protease Protection Assay 
In vitro translation samples were adjusted to 10 mM CaCI2 and incubated 
in the presence or absence of 0.1 mg/ml proteinase K as described previ- 
ously (Eble et al., 1986).  Representative samples of d856,  d665,  and d531 
translation reactions were solubilized with 1% NP-40 before addition of the 
protease. After an incubation period of 1 h on ice, all samples received 5 
mM  phenylmethylsulfonyl fluoride  (PMSF;  Sigma  Chemical  Co.,  St. 
Louis,  MO)  protease inhibitor  (final  concentration) in  DMSO  (Sigma 
Chemical Co.) and directly transferred into tubes containing boiling 1% 
SDS in 100 mM Tris-HCI, pH 9.0, buffer and allowed to incubate for 5 min. 
Samples were then placed on ice, solubilized with RIP lysis buffer, and as- 
sayed for HIV-1 proteins by RIP and SDS-PAGE. 
Carbonate Extraction 
Membranes from in vitro-translated fractions were sedimented by centrifu- 
gation of the translation mixtures for 10 min in an airfuge (Beckman Instru- 
ments Inc., Palo Alto, CA) at 20 psi air pressure. The resulting pellets were 
resuspended in either PBS containing 2% heat inactivated FBS or 0.1  M 
Na2CO3, pH 11.4 (Fujiki et al.,  1982) and allowed to incubate for 30 min 
on ice. Membranes were sedimented again by centrifugation and both the 
membrane pellet and supernatant fractions were collected, solubilized in 
RIP lysis buffer,  immunoprecipitated with PB33  antiserum, and fraction- 
ated by SDS-PAGE. Similar analysis of the d41Ct protein was conducted 
using RK773 antiserum and fractionation in  15 % polyacrylamide gels. 
Sequence-specific Antibody Binding 
At the end of translation-translocation reaction ofd856 protein, intact vesi- 
cles were isolated by centrifugation in an airfuge, and aliquots of the result- 
ing membrane fraction reacted with the various sequence specific antisera 
for 1 h on ice. Vesicles were then washed free of unconjugated antibody, 
solubilized in RIP lysis buffer, and the antigen-antibody complexes were 
bound to Staph A. Unbound proteins were assayed from the post-Staph A 
supernatants by the further addition of antisera and Staph A. The adjunct 
experiment to test the efficiency  of RK773 antiserum to react with its epitope 
was as follows: translation samples were solubilized in 20 mM Tris-HCl, 
pH 7.4, 5 mM EDTA buffer supplemented with either 1, 0.5, or 0.1% Triton 
2. The sequences presented are homologous to the sequences in the gpl60 
analyzed in this study with the exception of a single amino acid residue sub- 
stitution at position 737 of G to D. 
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ther PB33 or RK773 antisera as mentioned previously. 
Results 
Expression of  HIV-I Antigens In Vitro 
To identify the domains of the HIV-1 envelope glycoprotein 
that are associated with cellular membranes, the transloca- 
tion  of recombinant  gpl60  (d856  gene)  was  investigated 
along with that of two truncated variants that terminated at 
amino acid residues 665 and 531,  respectively (Fig.  1 A). 
The gene encoding the first variant, d665, was generated by 
insertion of a translational stop codon immediately down- 
stream of the codon corresponding to amino acid residue 665 
of the d856 gene. This allowed for the deletion of all amino 
acids downstream of  that site that included the second hydro- 
phobic domain of gp41  (Berman et al.,  1988). The second 
truncated variant, d531,  was generated by introduction of a 
translational stop codon immediately after the codon corre- 
sponding to amino acid residue 531 located within the first 
hydrophobic domain of gp41  (Lasky et al.,  1986). mRNAs 
from the three genes, d856, d665, and d531, were transcribed 
using the bacteriophage SP6 promoter system and translated 
in rabbit reticulocyte lysates. To analyze the translation prod- 
ucts, four polyclonal antisera were obtained from rabbits im- 
munized with various gpl60 derived peptides  (Fig.  1 B). 
Briefly, PB33 reacts with recombinant gp120 (Lasky et al., 
1986), PB12 reacts with peptide 542-641 ofgp41 (Cabradilla 
et  al.,  1986),  and  RK22  and  RK773  recognize residues 
728-745 and 839-853, respectively (Kennedy et al.,  1986, 
1987; Chanh et al.,  1988; R. Kennedy, personal communi- 
cation). 
The mRNA transcribed from the d856 gene, encoded pri- 
marily a protein that migrated in SDS-PAGE with an appar- 
ent molecular mass of 88 kD (Fig. 2 A, lane A). This protein 
was  processed in  the  presence of exogenous microsomal 
membranes to yield a major product of 150 kD (lane B, top 
band). Endo H digestion studies (lane D) demonstrated that 
this difference in molecular masses was due to the incorpora- 
tion of the high mannose type of N-linked carbohydrate side 
chains which are known to be attached cotranslationally to 
nascent polypeptides as they are translocated into the lumen 
of the microsomal membranes (Hubbard and Ivatt,  1981). 
The disparity in size of the endo H-digested species relative 
to the unglycosylated proteins (lane D vs. lanes A or C) can 
be attributed to residual N-acetylglucosamine residues bound 
to the asparagines in the polypeptide backbone (Tarentino et 
al.,  1974).  This was confirmed by digestion of the translo- 
cated species with N-glycanase (data not shown). A second 
glycosylated species of 115 kD was detected as a minor band 
upon translation of  the d856 mRNA in the presence of  micro- 
somes (lane B, lower band).  As seen in Fig. 2, both of the 
glycosylated species could be specifically immunoprecipi- 
tated with PB 33 (lane B) and with PB12 (lane F) antisera, 
indicating that they had the same polypeptide backbone up 
to amino acid residue 641 (see epitope for PB12). However, 
only the larger species could be immunoprecipitated with the 
RK22 (lane H) and RK773 (lane J) antisera raised against 
peptides located in the carboxy-terminal domain of gp41, in- 
dicating that the smaller species lacked the sequences that in- 
cluded these two epitopes. Thus, the 115 kD protein appears 
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Figure 1.  Schematic presentation of recombinant HIV-1 envelope 
glycoprotein and truncated variants. (A) The fragment of  the herpes 
simplex virus gD-1 gene encoding the signal sequence and 27 amino 
acid residues of the mature amino terminus were fused to the env 
gene of HIV-1 at a position corresponding to amino acid 61 as de- 
scribed previously (Lasky et al.,  1986; Berman et al.,  1988) to 
generate a chimeric gpl60 gene termed d856. Truncated variants, 
d665 and d531, were generated by introduction of stop translation 
codons immediately after the codons for amino acid residues 665 
and 531, respectively (Berman et al.,  1988; Lasky et al.,  1986, 
respectively). The d41Ct gene was engineered by fusion of the 
carboxy-terminal sequences of gpl60 (710-856) to the gD-1 se- 
quences as described previously for the d856 construction.  (B) 
Schematic representation of the specificity of the antisera used in 
the present studies. IJ., gD-1 signal and amino-terminal sequences. 
[], hydrophobic regions. 
to be generated by cleavage of the 150-kD species within the 
gp41  region at a site NH2-terminal to residue 752. 
In vitro biosynthesis of proteins encoded by the truncated 
gpl60 variants, d665 and d531, showed that they were simi- 
larly translocated across the microsomal membranes. Thus, 
the protein encoded by the d665 gene migrated at ~67 kD 
in the absence of membranes  (Fig.  2  B,  lane A)  and was 
modified to 126 kD in the presence of membranes (lane B, 
top band). The protein encoded by the d531 gene was synthe- 
sized as a 50-kD protein in the absence of membranes and 
as a  ll0-kD protein in the presence of membranes (Fig. 2 
C, lanes A and B, respectively). Both the 126-kD d665 pro- 
tein as well as the ll0-kD d531 protein were sensitive to endo 
H digestion (lane D vs. lane B, in B and C, respectively), in 
contrast to their untranslocated counterparts (lane C vs. lane 
A, in B and C, respectively). Proteolytic processing of the 
mature d665 gave rise to a smaller glycosylated species that 
migrated at '~,115 kD (B, lane B, lower band;  more clearly 
evident in Figs. 3 and 4). As expected, none of the proteins 
encoded by the d665 gene or the d531 gene could be immu- 
noprecipitated with either RK22 or RK773 antisera (lanes 
G-J in Fig. 2, B and C, respectively). Moreover, PB12 an- 
tiserum  specifically  immunoprecipitated  only  the  larger 
d665 glycoprotein suggesting that the proteolytic processing 
was occurring upstream of the PB12 epitope (Fig. 2 B, lane 
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In vitro  transcription  reaction mixes containing the  appropriate 
mRNAs were added to rabbit reticulocyte lysates supplemented 
with 15 ~tCi/Ixl L-[35S]methionine.  Translation reactions were car- 
ried out in the absence (lanes A, C, E, G, and I) and presence (lanes 
B,  D,  F,  H,  and J)  of exogenous microsomal  membranes.  To 
confirm translocation across the membranes parallel samples were 
assayed for N-linked oligosaccharide side chain addition by treat- 
ment with endo H (lanes C and D). At the end of translation, the 
reaction mixtures were analyzed for HIV-1 polypeptides by RIP 
using the sequence-specific  antisera (PB33 [lanes A-D], PB12 [lanes 
E and F], RK22 [lanes G and HI, and RK773 [lanes I and J]) and 
fractionation by SDS-PAGE in 7 % polyacrylamide gels. A presents 
the d856 encoded species. B presents the truncated d665 encoded 
species. C presents the truncated d531 encoded species. Molecular 
mass standards (shown on the right side of  the figure) are as follows: 
myosin H chain, 200 kD; phosphorylase b, 97.4 kD; BSA, 68 kD; 
and ovalbumin, 43 kD. 
F).  Thus,  the transcription-coupled translation system al- 
lowed for the expression and identification of several forms 
of  the HIV-1 envelope glycoprotein and permitted direct anal- 
ysis of its translocation and membrane topology. 
Analysis of  the Translocated  Glycoproteins by 
Protection  from Exogenous  Protease  Digestion 
Previously it has been shown that the system employed in the 
present studies directs the vectorial translocation of nascent 
membrane-bound and secreted proteins into the interior of 
the  microsomal  vesicles  (Blobel  and  Dobberstein,  1975; 
Walter  et  al.,  1984).  Proteins  that  lack  stop-transfer  se- 
quences (e.g., secreted proteins) are completely translocated 
into  the  interior of the  microsomal vesicles and  become 
resistant to digestion with exogenous protease by virtue of 
their compartmentalization (Eble et al.,  1986). The biosyn- 
thesis of proteins that possess stop-transfer sequences (e.g., 
membrane-bound proteins) differs from that of secreted pro- 
teins in that they are incompletely translocated into micro- 
somal vesicles. In this case, translocation is arrested at the 
stop-transfer sequence, leaving regions COOH-terminal to it 
exposed on the outside of the vesicles (cytoplasmic surface) 
and susceptible to digestion by exogenous protease. Thus, 
addition of protease to the reaction mixture after completion 
of the translocation reaction, in principle, allows one to dis- 
tinguish between completely translocated, protease-resistant 
secreted proteins and incompletely translocated, protease- 
sensitive membrane proteins. Moreover, the binding of se- 
quence specific antibodies to incompletely translocated pro- 
teins permits the localization of specific domains on either 
side of the microsomal membrane. Fig.  3 illustrates a pro- 
tease protection experiment in which the translation-translo- 
cation products were incubated with or without proteinase K 
in the presence or absence of NP-40. At the end of digestion, 
the vesicles were disrupted with RIP lysis buffer and their 
contents analyzed by RIP. In this study, the 150-kD d856 pro- 
tein was readily cleaved by proteinase K in the absence of de- 
tergent as was evident by a shift in mobility on SDS-PAGE 
relative to control undigested protein equivalent to ,~16 kD 
(lane D vs. lane C, arrows). This novel 134-kD species (lane 
D, lower  arrow) was similar to untreated d856 protein (lane 
C, upper  arrow) in that it could be immunoprecipitated with 
PB33 and PB12 antiserum (lanes D and F, respectively), but 
differed in that it was not reactive with either the RK22 or 
RK773 antisera (lanes G and H, respectively). These results 
suggested  that proteinase K  treatment of the  translocated 
d856-derived protein destroyed the epitopes recognized by 
the RK22 and RK773 antisera. In contrast to the 150-kD spe- 
cies, the smaller glycosylated (115-kD) protein derived from 
d856 was sensitive to protease digestion only when the vesi- 
cles were permeabilized with NP-40 (lane E vs. lanes C and 
D) suggesting that it was translocated across the membrane 
into the lumen of the vesicles. 
In similar studies, both glycosylated species encoded by 
the d665 gene, which lack the second hydrophobic domain 
ofgp41, were found to be resistant to protease digestion (lane 
L  vs.  lane K) unless the vesicles were first permeabilized 
with NP-40 (lane M). Moreover, the PB12 antiserum immu- 
noprecipitated the same size protein from protease treated 
d665 translation-translocation product as did the PB33 an- 
tiserum with control undigested samples (lane Nvs. lane K). 
Together these studies  suggested that amino acid residues 
The Journal of Cell Biology, Volume  107, 1988  1680 Figure 3. Protection of the translated proteins from protease digestion. Translation of mRNAs encoding d856 (lanes A-H), d665 (lanes 
l-N), and d531 (lanes O-S) proteins were carried out in the absence (lanes A and B, I and J, and O and P) and presence (lanes C-H, 
K-N, and Q-S) of added microsomal membranes. At the end of translation, samples were adjusted to 10 mM CaC12 and treated with or 
without 0.1 mg/ml proteinase K for 1 h on ice. Certain samples (lanes E, M, S) were solubilized with 1% NP-40 before digestion. Digestion 
was arrested by the addition of 5 mM PMSF/DMSO and reaction mixtures were rapidly transferred into boiling 1% SDS in 100 mM Tris, 
pH 9.0. Radiolabeled samples were then assayed for HIV-1 proteins by immunoprecipitation with PB33 (lanes A-E, l-M, and O-S), PB12 
(lanes F and N), RK22 and RK773 (lanes G and H, respectively) antisera, and fractionation by SDS-PAGE in 7% polyacrylamide gels. 
Molecular mass standards (to the right of the figure) are as described in Fig. 2. 
542-665,  which are located between the two hydrophobic 
domains of gp41 and included the epitope for PB 12,  were 
protected from protease digestion and thus,  like authentic 
secretory proteins, were completely translocated into the lu- 
men of the microsomal vesicles. The d531-encoded protein 
which lacked all of  the second and most of the first hydropho- 
bic domains of gp41,  was also completely protected from 
protease digestion in the absence of  detergent (lane R vs. lane 
S). Control studies conducted in the absence of microsomal 
membranes showed that the untranslocated d856, d665, and 
d531  proteins were all susceptible to proteolytic digestion 
(lane B vs. lane A, lane J  vs.  lane I, and lane P  vs.  lane O, 
respectively). Together these results suggested that while the 
first hydrophobic domain (residues  512-541)  of the HIV-1 
envelope antigen was not sufficient for arresting the protein 
in the membrane, a region located COOH-terminal to resi- 
due  665,  and  NH2-terminal  to  epitope  recognized by the 
RK22 antisera (728-745) functioned as a conventional stop- 
transfer sequence. 
Carbonate Extraction of Translocated Proteins 
To further explore the function of the first hydrophobic do- 
main in gp41,  carbonate extraction studies were conducted 
to determine whether species that contained only this domain 
might be peripherally associated with membranes by virtue 
of their interaction with the lipid bilayer. Previous studies 
have shown that treatment of microsomal vesicles with a ba- 
sic  solution  of  sodium  carbonate  lyses  the  vesicles  and 
releases peripheral membrane proteins while preserving the 
integrity of  the lipid bilayer and any associated integral mem- 
brane species (Fujiki et al., 1982). Thus, treatment with high 
pH carbonate interferes with ionic noncovalent protein-pro- 
tein interactions but preserves hydrophobic protein-lipid in- 
teractions. In the present studies, proteins derived from the 
d856, d665, and d531 genes were translated in the presence 
of microsomal membranes.  At the end of the translation- 
translocation reaction, the membranes were isolated by cen- 
trifugation and resuspende$1 in either PBS containing heat in- 
activated  FBS  or  with  sodium  carbonate  (pH  11.4).  The 
membranes  were  reisolated  by  centrifugation,  and  both 
membrane and supernatant fractions were solubilized with 
RIP lysis buffer. The membrane-bound species (nonextract- 
able)  as  well  as  supernatant-derived  species  (extractable) 
were analyzed by immunoprecipitation with PB 33 antise- 
rum. Fig. 4 (lanes A, B, E, F, I, and J) showed that in the 
absence of carbonate all of the expressed proteins were de- 
tected in the sedimented membrane pellet (M) which is ex- 
pected for a preparation of unbroken vesicles. However, after 
carbonate extraction it was observed that virtually all the full 
length d856 glycoprotein remained associated with the mem- 
brane fraction (lane C), while the smaller proteolytic frag- 
ment of d856  protein (ll5-kD  species) was  now detected 
mainly in the supernatant (S) fraction (lane D  vs.  lane C). 
Similarly, the smaller d665 protein (lane H vs. lane G) and 
the d531 protein (lane L vs. lane K) were detected in the su- 
pernatant fractions after extraction. These results are consis- 
tent  with  the  idea  that  these  three proteins  were  soluble 
within the vesicles due to complete translocation across the 
membranes. Interestingly however, the larger 126-kD d665 
glycoprotein was present in both the M and S fractions with 
the greater portion of it being in the S fraction (lane H vs. 
lane G). 
Haffar et al.  Topogenesis ofHIV-I gpl60  1681 Figure 4. Identification of membrane-bound proteins by carbonate extraction. This figure depicts d856 (lanes C and D), d665 (lanes G 
and H), and d531 (lanes K and L) encoded proteins extracted from microsomal membrane pellets with 0.1 M sodium carbonate pH 11.4. 
After treatment with carbonate, the membranes were sedimented by centrifugation, and the supernatants (S) were isolated from the mem- 
brane pellets (M). Membrane-bound proteins, i.e., not extracted with carbonate, are shown in lanes C, G, and K, while soluble and extracted 
proteins are shown in lanes D, H, and L. Control samples (lanes A and B, E and F, and 1 and J) in which the initial membrane pellets 
were not solubilized with carbonate were run in parallel.  All samples were immunoprecipitated with PB33 antisera and fractionated in 
7% polyacrylamide gels. Molecular  mass standards (to the right of the right of the figure) are as described  in Fig. 2. 
Binding of  Antibodies Specific for the 
Carboxy Terminus of  gpl60 Suggests that it Associates 
with Microsomal Membranes 
The results obtained thus  far were consistent with the hy- 
pothesis  that  the  HIV-1  envelope  glycoprotein  precursor, 
gpl60,  was a  bitopic  integral membrane protein that con- 
tained a single stop-transfer sequence. As such, upon trans- 
location,  discrete  domains  of the  glycoprotein  would  be 
oriented  either  intravesicularly  or  extravesicularly.  These 
domains could be defined by binding  of sequence-specific 
antibodies to intact vesicles. To explore this hypothesis, in- 
tact  vesicles containing  translocated  d856-derived  protein 
were  isolated  by  centrifugation  and  reacted  with  PB33, 
PB12,  RK22,  and RK773  antisera.  Membranes were then 
washed free of unbound antibody, solubilized with RIP lysis 
buffer, and antibody-antigen complexes were sedimented af- 
ter adsorption to Staph A.  Antigens not bound by antibody 
were thus  localized  in  the  post-Staph A  supernatant  frac- 
tions, and were assayed by the further addition of antisera. 
Immunoprecipitated HIV-1  proteins  from the  supernatants 
(S) and the initial Staph A pellets (P) are presented in Fig. 
5.  In those samples that were reacted with either PB33 or 
PB12 antisera, the proteins were preferentially found in the 
supernatants  (lane  B  vs.  lane  A,  and  lane  D  vs.  lane  C, 
respectively). In contrast,  RK22  reacted with d856  glyco- 
protein in the initial membrane pellets (lane E vs. lane F). 
These results revealed that whereas the epitope for RK22 was 
readily accessible for binding while the protein was still as- 
sociated with the membrane, those of PB33 and PB12  were 
protected by virtue of their lumenal disposition. These find- 
ings are consistent with a bitopic orientation revolving around 
the  second  hydrophobic  domain  in  the  carboxy-terminal 
region gp41. 
An intriguing result however was the observation that the 
RK773  antiserum  (directed  against  amino  acid  residues 
839-853) did not react with vesicle-bound d856 protein, as 
evident by its localization in the supernatant fraction (lane H 
vs. lane G). Since RK773 was generated against a synthetic 
peptide it is conceivable that the antiserum reacts preferen- 
tially with the linearized epitope and does not recognize the 
secondary structure assumed when part of the whole protein. 
Moreover, this result could be due to masking of the anti- 
genic epitope by its folding into the interior of the protein. 
To address this question, we replaced our standard RIP lysis 
buffer that contained NP-40 and low concentrations of the 
denaturants SDS and deoxycholate with another buffer sup- 
plemented only with low concentrations of the nonionic de- 
tergent Triton X-100 and no SDS or deoxycholate. This ex- 
periment  allowed  us  to  test  directly  whether  the  RK773 
antibodies were able to react with their epitope simply by 
permeabilizing the  vesicle membranes without denaturing 
The Journal of Cell Biology, Volume  107,  1988  1682 Figure 5.  Sequence-specific antibody binding 
to  translocated  d856. After  translation  and 
translocation of d856, microsomal membranes 
were sedimented by centrifugation in an air- 
fuge.  Membranes  were  then  resuspended  in 
PBS containing 2 % heat inactivated FBS and 
incubated with the appropriate antisera for 1 h 
on ice then washed free of unconjugated anti- 
body. After lysis of the vesicles, antibody-anti- 
gen  complexes were  adsorbed  to  Staph A, 
sedimenled by centrifugation, and represented 
the  pellet  (P)  fractions.  Unbound  antigens 
were assayed from the post-Staph A superna- 
tants, S fractions, by the standard RIP analysis. 
HIV-1 antigens were fractionated in 7 % poly- 
acrylamide gels. Molecular mass standards (to 
the right of  the figure)  are as described in Fig. 2. 
PB33, lanes A and B; PB12, lanes C and D; 
RK22, lanes E  and F;  and RK773, lanes  G 
and H. 
the protein product. Thus, after translating the d856 mRNA 
in  the presence of exogenous membranes,  we treated the 
translation mixtures with 20 mM Tris-HCl, pH 7.4, 5 mM 
EDTA buffer containing various concentrations (1,  0.5,  or 
0.1%) of Triton X-100. As seen in Fig. 6 (lanes D-F) antise- 
rum RK773  was capable of immunoprecipitating both the 
undenatured translocated as well as untranslocated d856 spe- 
cies  in  all  three detergent concentrations  (see  upper  and 
lower arrows,  respectively). The  experimental conditions 
used  clearly  permeabilized  the  vesicle  membranes  since 
PB33  antiserum  was  able to  react with  both glycosylated 
d856 species (Fig. 6, lanes A-C, upper and middle arrows). 
The uncommon background present in Fig. 6, lanes D-Fwas 
also present in lanes A-C at simdar exposures of the autora- 
diogram and was mainly due to the buffer used since parallel 
experiments with the normal RIP buffer did not generate this 
background. The results of this experiment suggested that in 
the  absence of known denaturants  SDS  and  deoxycholate 
normally found in our RIP lysis buffer, RK773 reacted with 
its epitope efficiently. Thus, protection of this epitope from 
its antibody in intact vesicles (Fig. 5) could not be accounted 
for by either the secondary structure or the folding of  the pro- 
tein under nondenaturing conditions. We therefore consid- 
ered the alternative possibility that masking of the epitope 
was due to interaction with the membrane bilayer. To analyze 
this  putative  interaction,  the  carboxy-terminal domain  of 
gp41,  starting at the codon for amino acid residue 710 and 
ending at the codon for residue 856 was fused in frame and 
downstream of the herpes gD-1 signal sequence (Fig.  1 A). 
When this chimeric gene (d41Ct) was transcribed and trans- 
lated in vitro, it encoded a protein of 22 kD which became 
modified to 26.5 kD in the presence of microsomes (Fig. 7 
A, lanes A and B, middle and top arrow, respectively). This 
shift in size is consistent with attachment of high mannose 
core carbohydrate at the two potential N-linked glycosylation 
sites  (Asn-X-Ser/Thr)  at  residues  750  and  816. Digestion 
with endo H generated a species smaller than the native un- 
translocated protein (19.5 kD),  consistent with the shift in 
size due to cleavage of the signal sequence (Fig.  7 A, lane 
C vs.  lane A, bottom arrow vs.  middle arrow). The 22-kD 
species in lane C represents the residual untranslocated pro- 
tein, the relative amount of which was not surprising since 
we had noted that the efficiency of translocation of proteins 
was directly related to the age of the microsomal preparation. 
When translation mixtures were subjected to carbonate ex- 
traction as described earlier, the translocated d41Ct protein 
remained completely associated with the membrane and not 
the supernatant fraction (Fig. 7 B, lane C vs. lane D), similar 
to the unextracted control samples (Fig. 7 B, lane A vs. lane 
B).  This  result,  together with  cleavage of the  signal  se- 
quence, suggested that the peptide COOH-terminal to the 
second hydrophobic domain of gp41, which does not contain 
sequences typical of stop transfer sequences, was neverthe- 
less associated with the lipid bilayer. The apparent reduction 
in size of the protein after treatment with carbonate (Fig. 7 
B, lane Cvs. lane A) was not due to aberrant proteolysis since 
the  same  size  species  could be  radioimmunoprecipitated 
with PB33 antiserum which reacts with the amino terminal 
gD-I  sequences  (Fig.  1 B),  as  well as  with the carboxy- 
terminal-specific RK773 antiserum (data not shown). 
Discussion 
In this study,  we report our findings on the topogenesis of 
Haffar et al,  Topogenesis ofHlV-1 gpl60  1683 Figure 6.  Microsomal  membranes protect RK773 
epitope from binding  by the antibody in intact vesi. 
cles. Translation mixtures containing  microsomes 
and translocated proteins were solubilized in 20 mM 
Tris-HCl, pH  7.4,  5  mM EDTA buffer  supple- 
merited with either 1, 0.5, or 0.1% Triton X-100 de- 
tergent  (lanes A and D,  B and E,  and C and F, 
respectively).  The solubilized  samples were vor- 
texed  vigorously  and  then  immunoprecipitated 
with either PB33 antiserum (lanes A-C) or RK773 
antiserum  (lanes  D-F).  The  antibody-antigen 
complexes  were  reacted  with Staph A and sedi- 
mented by  centrifugation.  The  Staph  A  pellets 
were  washed  several  times  with  the  1%  Triton 
X-100 buffer before washing twice with the stan- 
dard  RIP wash buffer. The protein species  were 
then fractionated by SDS-PAGE in 7% polyacryl- 
amide  gels  and  visualized  by  autoradiography. 
Molecular mass markers (to the right of the figure) 
are as described  in Fig. 2. 
Figure  7.  Association  of  gp41 
carboxy-terminal sequences with 
microsomal membranes. Transla- 
tion of d41Ct mRNA  was  con- 
ducted in the absence (A, lane A) 
and presence (A, lanes B and C, 
and B,  all  lanes)  of exogenous 
microsomes. The translation prod- 
ucts  were  analyzed  directly  by 
RIP using the PB33 antiserum (A, 
-). To show cleavage of the sig- 
nal  sequence  concomitant with 
translocation  across  the  mem- 
branes, the  translocated  species 
was subjected to endo H digestion 
to remove the carbohydrate moie- 
ties and expose the peptide back- 
bone (A, lane C vs. lanes A and B, 
bottom arrow vs. middle and top 
arrows). B presents the extraction 
of translocated d41Ct protein from 
isolated microsomal membranes with basic carbonate buffer as described in Fig. 4. After extraction,  the membrane pellet (lanes A and 
C) and supernatant (lanes B and D) fractions  of control samples and treated  samples (lanes A and B and lanes C and D, respectively) 
were analyzed for d41Ct species by RIP with RK 773 antiserum. Proteins depicted in A and B were fractionated  in 15% polyacrylamide 
gels.  Molecular mass standards  are as follows: carbonic anhydrase,  30 kD; and lysozyme,  14 kD. 
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branes.  Differential antibody-binding studies (Fig.  5)  and 
protease protection analysis (Fig. 3) demonstrated that the 
150-kD  d856 protein was incompletely translocated across 
the microsomal membranes. The fact that PB33 and PB12 
antisera reacted with the translocated glycoprotein only after 
detergent lysis of the microsomal membranes, suggested that 
the epitopes recognized by PB33 and PB12 antisera (61-510 
fused to the 27 amino terminal gD-1 residues and 542-641, 
respectively) were oriented to the lumen of the microsomal 
vesicles  (Fig.  8),  which corresponds  to  the  extracellular 
compartment on mature virions or virus-infected cells. Con- 
versely, RK22 antiserum recognized membrane-bound d856 
before detergent lysis, suggesting that its epitope (residues 
728-745) was located on the exterior of the microsomal vesi- 
cles, corresponding to the internal or cytoplasmic compart- 
ment of virions and virus-infected cells (Fig.  8).  Inspection 
of the amino acid sequence of gpl60 revealed that peptide 
684-707  delineated the only sequence COOH-terminal to 
residue 641 and NH2-terminal to residue 735 that possessed 
features typical of transmembrane domains or stop-transfer 
sequences (Sabatini et al.,  1982;  Adams and Rose,  1985; 
Davis et al., 1985). Protease digestion studies revealed a 16- 
kD decrease in electrophoretic mobility of  d856 after proteo- 
lytic digestion, consistent with the predicted change in mo- 
lecular mass due to the loss of ~148 amino acids located 
downstream of the second hydrophobic domain of gp41. In 
contrast to the 150-kD d856 protein, both the smaller (115 
kD) d856 species, as well as the d665 protein, which con- 
tained the first hydrophobic domain of gp41 (residues 512- 
541), were fully protected from protease digestion and were 
completely translocated across the membranes. The incom- 
plete extraction of  the 126-kD d665 protein from membranes 
by basic carbonate treatment argued that at least a portion 
of the truncated protein was able to interact with the lipid 
bilayer, albeit to a lesser extent than the 150-kD d856 species 
(Fig. 4). This interaction did not appear to be mediated by 
the first hydrophobic domain of gp41, since the smaller 115- 
kD d856,  which also contained this domain, was quantita- 
tively extracted with carbonate treatment. Moreover, phase 
separation analysis in Triton X-114 (Bordier,  1981; Alcaraz 
et al.,  1984) revealed that both the d665 and d531 variants 
partitioned completely into the aqueous phase, a characteris- 
tic of secreted soluble proteins (data not shown). Therefore, 
this finding could represent either limited solubility of the 
larger d665 protein in the presence of alkali, or might be a 
reflection of the presence of two conformationally distinct 
populations of d665: one with the first hydrophobic domain 
of gp41 (residues 512-541) folded into the interior of the mol- 
ecule (supernatant material) and the other an unfolded mole- 
cule with the hydrophobic domain exposed to the aqueous 
environment (residual membrane fraction). Results from in 
vivo studies of the expression of gp 160 variants terminating 
at residues 665  in mammalian cells (Kowalski et al.,  1987; 
Berman et al., 1988) agreed with the in vitro studies in that 
the truncated proteins were  secreted into the  cell culture 
medium and were not detected on the surface of transfected 
cells. More recently, it has been found that a gpl60 truncated 
variant terminating at amino acid residue 683 was similarly 
secreted into the cell culture medium of transfected CHO 
ceils (Nakamura G.,  W.  Nunes,  O.  Haffar,  L.  Riddle, T. 
Gregory, and P. W. Berman, manuscript in preparation). 
Since  the  first  hydrophobic  domain  of gp41 (residues 
512-541) failed to function as a stop-transfer sequence, this 
region must serve another role in the native molecule. One 
characteristic of  HIV-1 infection is the formation of large syn- 
cytia between infected and uninfected CD4*T lymphocytes 
(Barrt-Sinoussi et al., 1983; Popovic et al., 1984; Lifson et 
al., 1986a, b; Sodoroski et al., 1986) that is mediated through 
the  specific  interaction  of gpl20  with  the  CD4  protein 
(McDougal et al., 1986a, b; Lasky et al., 1987). Mutations 
in the first hydrophobic region of gp41 reduced the fusagenic 
activity of the variant proteins as determined by the absence 
of syncytia formation in transfected cell cultures (Kowalski 
et al., 1987). Recently, it has been reported that the 512-541 
domain contained a tandem repeat of a consensus sequence 
(Phe-X-Gly)  found in the amino terminus of fusion proteins 
of  several  paramyxoviruses  (Gallaher,  1987; Gonzalez- 
Scarano et al., 1987). Thus by direct mutational analysis and 
by analogy to paramyxoviruses and other retroviruses such 
as mouse mammary tumor virus (Redmond et al., 1984), the 
first hydrophobic region of gp41 transmembrane protein ap- 
pears to be the fusion domain of HIV-1. 
The apparent inaccessibility of RK773  antiserum to its 
epitope when gpl60 was integrated in the membrane (Fig. 
5),  and the finding that this observation could not be ac- 
counted for by either the secondary or tertiary structure of 
the protein but was due to the intervening lipid bilayer (Fig. 
6) raised the question regarding the association of the cyto- 
plasmic tail of gpl60 with the membrane. To investigate this 
possibility, we expressed the peptide 710-856 as a separate 
fusion protein, d41Ct (Fig. 1 A and Fig. 7). Carbonate treat- 
ment of the translocated d41Ct failed to extract the protein 
from the membrane fraction, suggesting that it was  inte- 
grated in the lipid bilayer. This interaction was not mediated 
by the amino-terminal signal sequence since endo H diges- 
tion analysis suggested that the signal sequence was cleaved 
from the translocated species (Fig. 7). Recently, we have also 
expressed the d41Ct gene in a transient mammalian cell cul- 
ture system and have shown by various criteria that the en- 
coded glycoprotein was exported to the cell surface as well 
as secreted from the cells (Haffar,  O. K., D. J. Dowbenko, 
and P. W. Berman, manuscript in preparation). At the pres- 
ent time we do not know whether the cytoplasmic tail of gp41 
actually traverses the bilayer or is associated peripherally 
with it. Inspection of the amino acid sequence of d856 failed 
to reveal  any region typical of membrane binding domains 
(Sabatini et al., 1982; Adams and Rose, 1985; Davis et al., 
1985) downstream of the defined membrane anchor region 
(residues 684-707). Interestingly however, it had been noted 
by D.  Eisenberg (personal communication) that an amphi- 
pathic a-helix (Eisenberg et al., 1984) was formed by resi- 
dues 833-849 which overlap the RK773 epitope (839-853). 
This  helix  was  recently reported  to  extend from residue 
824-856  (E  Carson, personal communication). Computer 
homology matching of this COOH-terminal region of gp41 
from 10 different HIV-1 isolates revealed a remarkable con- 
servation of the amphipathic a-helical secondary structure 
(data not shown).  Given the polar nature of amphipathic 
a-helices, it is thermodynamically  unlikely that such a struc- 
ture crosses the membrane independently. For it to cross the 
membrane, it most likely would require an interaction with 
another  amphipathic  a-helix  of  complementary  polarity 
similar to that described for ion channel proteins (Finer- 
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Figure 8. Model for the orientation of HIV-1 recombinant gpl60 in 
microsomal membranes. The present studies suggested that gpl60 
spans microsomal membranes once using the second hydrophobic 
domain in the gp41 (amino acid residues 684-707 designated by an 
open box) as a stop-transfer sequence. All sequences NH2-termi- 
nal to residue 684 which include the first hydrophobic domain in 
gp41 (residues 512-541 designated by the colored box) and extend 
through the NH2-terminus of mature native gpl60 (residue 31) are 
thus oriented to the lumenal surface of intracellular vesicles (ex- 
tracellular surface). Conversely, sequences COOH-terminal to resi- 
due 707 are oriented to the outside of the vesicles (cytoplasmic sur- 
face). In this model, we also propose that the carboxy terminus of 
gp160 interacts with the membrane, although the specific sequences 
involved in this interaction have not been directly identified yet. The 
open arrowhead symbol points to the cleavage site (residues 510 and 
511) between gpl20 and gp41 regions of the envelope glycoprotein. 
Moore and Stroud,  1984).  More recently, a second amphi- 
pathic a-helix was identified that was composed of amino 
acid  residues  770-794  (E  Carson,  personal  communica- 
tion). Similar to the previously described helix this second 
structure was also conserved in the 10 HIV-1 isolates exam- 
ined (data not shown). It was suggested by E  Carson  s (per- 
sonal communication) that the two helices may form a stable 
interaction in the molecule by orienting themselves in a way 
that allows the formation of salt bridges between the appos- 
ing charged residues.  Although we do not have any direct 
evidence to show whether either or both of these domains are 
responsible for the association of the cytoplasmic tail with 
the  bilayer,  it  is  nevertheless  surprising  that  they  are  so 
highly conserved. Recently, this region ofgpl60 has been the 
focus of much interest regarding its contribution to the struc- 
ture and function of the virus. For instance, mutant virions 
generated by deletion of 18 amino acid  residues  from the 
carboxy-terminal end of their gpl60 were found to be nonin- 
fectious and not to form syncytia (E. Hunter, personal com- 
munication). 
In conclusion,  the use of in  vitro transcription-coupled 
translation and translocation systems has allowed us to ana- 
lyze the  orientation  of gpl60  in  microsomal membranes. 
These  studies  suggest that  the  mature  amino  terminus of 
gpl60 and all residues upstream of amino acid 665 are ex- 
posed on the surface of virions and virus-infected cells. The 
hydrophobic  region  delineated  approximately by  residues 
684-707  appears to  function  as a  transmembrane domain 
3. This was presented at the Fourth International  Congress on AIDS, Stock- 
holm, Sweden, June  12-16, abstract No.  1516. 
(stop-transfer sequence),  and  residues  COOH-terminal to 
this sequence comprise the cytoplasmic domain of the pro- 
tein. These results are inconsistent with the model for gpl60 
orientation in membranes previously proposed by Modrow 
et al. (1987)  which suggested that gpl60 spanned the bilayer 
three times by virtue of the two hydrophobic domains of gp41 
and a region located between the two domains, all three of 
which  were  theorized  to  function  as  transmembrane  do- 
mains.  Because our results  demonstrated that the  epitope 
recognized by the RK22 antiserum (residues 728-745)  was 
oriented  towards  the  cytoplasmic side  of the  microsomal 
membranes (Fig. 8), we cannot account for the reports that 
antisera specific to the sequence delineated by residues 722- 
752 were able to neutralize HIV-1 infectivity in vitro (Chanh 
et al.,  1986; Ho et al.,  1987).  Although the data presented 
is consistent with the simplest model of gpl60 orientation 
(i.e., that it is an integral membrane protein that contains a 
single stop-transfer sequence) our results suggest that gpl60 
forms a second association with the membrane bilayer near 
its  COOH  terminus.  We  are  currently  in  the  process  of 
elucidating the exact nature of this unique  interaction. 
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